📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Evidence for benefit of statins to modify cognitive decline and risk in Alzheimer's disease. (2017)

First Author: Geifman N

Attributed to: Manchester Molecular Pathology Innovation Centre (MMPathIC): bridging the gap between biomarker discovery and health and wealth funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/s13195-017-0237-y

PubMed Identifier: 28212683

Publication URI: http://europepmc.org/abstract/MED/28212683

Type: Journal Article/Review

Volume: 9

Parent Publication: Alzheimer's research & therapy

Issue: 1